ISDS Case Map
medicines
Mexico’s government said progress was being made toward revising a new North American trade pact that will sharply reduce protections for biologic drugs.
Generic versions of biologic drugs could come to market faster.
There are two solutions to this impending problem, which most political parties could agree to if they are truly committed to protecting the NHS.
Trading away our health: How trade and investment rules put corporate rights ahead of public health.
A Free Trade Agreement with the US will likely result in the amendment of the Patents Act, which could impact the Indian pharma industry.
The National Farmers Union says the new deal’s extended patent protection for new pharmaceuticals must be reduced so that less expensive generic versions of new drugs can be available to consumers sooner.
The mutual recognition agreement for inspections of manufacturing sites for human medicines in their respective territories can make it faster and less costly for both sides to bring medicines to the market.
Intellectual property barriers, which would hinder access to affordable medicines, have supposedly been removed from the draft RCEP free-trade agreement (FTA).
Three harmful provisions concerning pharmaceuticals and agriculture which were part of the RCEP have been withdrawn.
FTA Watch would like to urge the Thai negotiation team for the RCEP to have a
strong position to reject proposals on Intellectual Property Enforcement chapter.
